REY-GIRAUD AGNES 4

What Happened
Agnes Rey-Giraud, a director of GoodRx Holdings, was granted 73,434 restricted stock units (RSUs) on June 16, 2026. The reported acquisition price is $0.00 (transaction coded A for award/grant). This is a compensation award, not a purchase or sale of outstanding shares.

Key Details

• Transaction date: 2026-06-16 (Form 4 filed 2026-06-17; timely filing)
• Transaction type/code: Award/Grant (A)
• Shares/units granted: 73,434 RSUs; reported acquisition amount $0.00
• Shares owned after transaction: Not specified in the filing
• Footnote: Each RSU represents a contingent right to receive one share of Class A common stock. The RSUs vest in full on the earlier of (i) the one‑year anniversary of June 16, 2026 (i.e., ~June 16, 2027) or (ii) the date of the 2027 Annual Meeting of Stockholders, subject to continued service (footnote F1).

Context
RSUs are a form of equity compensation that convert into shares only if and when they vest; they are not an immediate purchase or sale and do not reflect an immediate change in market exposure. Director RSU grants are common as part of board compensation and should be viewed as compensation rather than a direct bullish or bearish trade signal.